Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Elife|May 3, 2023
Shared enhancer gene regulatory networks between wound and oncogenic programsSwann Floc'hlay, Ramya Balaji, Dimitrije Stanković, et al.Developmental Cell|September 5, 2017
YAP/TAZ Orchestrate VEGF Signaling during Developmental AngiogenesisXiaohong Wang, Aida Freire Valls, Géza Schermann, et al.Hepatology (Baltimore, Md.)|March 26, 2021
A Mouse Model of Cholangiocarcinoma Uncovers a Role for Tensin-4 in Tumor ProgressionMickaël Di-Luoffo, Sophie Pirenne, Thoueiba Saandi, et al.Journal of Hepatology|June 8, 2025
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiationAna Algueró-Nadal, Hasse Mol, Elena Zoppolato, et al.Nature Communications|April 14, 2015
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell stateAnnelien Verfaillie, Hana Imrichova, Zeynep Kalender Atak, et al.Plos Genetics|February 9, 2010
Genomic hotspots for adaptation: the population genetics of Müllerian mimicry in Heliconius eratoBrian A Counterman, Felix Araujo-Perez, Heather M Hines, et al.Proceedings of the National Academy of Sciences of the United States of America|August 24, 2005
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancerAstrid M Eder, Xiaomei Sui, Daniel G Rosen, et al.Gastroenterology|October 31, 2020
Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and CholestasisElisabeth Verboven, Iván M Moya, Leticia Sansores-Garcia, et al.Science (New York, N.Y.)|November 23, 2019
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in miceIván M Moya, Stéphanie A Castaldo, Laura Van den Mooter, et al.Pageof 6